EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contemporary Management of Adrenal Tumors

Gabriel Rodrigues, Philip Olson, Benjamin T. Ristau

Cancers · 20.11.2026 · 18 (22) · 3707

DOI: 10.3390/cancers18223707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 20.11.2026. Verfasst von Gabriel Rodrigues und 2 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Widespread use of high-resolution cross-sectional imaging has made the incidentally discovered adrenal mass a common clinical problem. Although most adrenal incidentalomas are non-functioning benign adenomas, clinicians must distinguish them from actionable pathology such as functional adenomas, adrenocortical carcinoma, and pheochromocytoma. This review outlines the contemporary diagnostic algorithm for adrenal incidentalomas and the main indications for surgical and medical intervention.

Methods

We performed a narrative review of current society guidelines and of the primary literature underlying their recommendations on anatomic, biochemical, and surgical evaluation, comparing recommendations and evidence grades where guidelines differ.

Results

Management is driven primarily by imaging phenotype, lesion size, and hormonal function. Unenhanced computed tomography attenuation ≤ 10 Hounsfield units is highly specific for a benign lipid-rich adenoma. Hormonal evaluation should exclude hypercortisolism in all patients and pheochromocytoma in all but asymptomatic patients with homogeneous, lipid-rich lesions, with testing for primary aldosteronism and androgen excess when clinically indicated. Minimally invasive adrenalectomy is standard for hormonally active benign adenomas and most pheochromocytomas, whereas open adrenalectomy remains preferred for suspected adrenocortical carcinoma that is large or locally invasive, to avoid tumor capsule rupture. Novel therapies, including peptide receptor radionuclide therapy, show efficacy in advanced disease.

Conclusions

Society guidelines agree on most of the diagnostic pathway but diverge on surveillance of large benign lesions, interpretation of cortisol testing, and the surgical approach to suspected carcinoma. A standardized, multidisciplinary approach that recognizes these differences and the strength of the underlying evidence optimizes outcomes while preventing unnecessary procedures.

Zitieren

APA

Rodrigues, G., Olson, P., & Ristau, B. T. (2026). Contemporary Management of Adrenal Tumors. Cancers, 18(22), 3707. https://doi.org/10.3390/cancers18223707

Vancouver

Rodrigues G, Olson P, Ristau BT. Contemporary Management of Adrenal Tumors. Cancers. 2026;18(22):3707. doi:10.3390/cancers18223707

BibTeX
@article{Rodrigues2026,
  author = {Rodrigues, Gabriel and Olson, Philip and Ristau, Benjamin T.},
  title = {Contemporary Management of Adrenal Tumors},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3707},
  doi = {10.3390/cancers18223707}
}
Kostenlos starten →